Literature DB >> 32960397

Glomerulosclerosis predicts poor renal outcome in patients with idiopathic membranous nephropathy.

Cuimei Wei1,2, Yongcheng He3,2, Tong Li4,5, Haofei Hu3,2, Haiying Song3,2, Dongli Qi3,2, Yuan Cheng3,2, Jia Chen3,2, Mijie Guan3,2, Xiaohua Xiao1,2, Junyi Li6.   

Abstract

OBJECTIVE: This study aimed to investigate the association between the proportion of glomerulosclerosis (focal segmental glomerulosclerosis and/or global glomerulosclerosis) and renal prognosis in patients with idiopathic membranous nephropathy (IMN).
METHODS: A retrospective analysis performed from January 2008 to December 2017 in the First Affiliated Hospital of Shenzhen University by renal biopsy confirmed 200 patients with IMN, and their clinical pathology and prognosis were compared. Patients were divided into three groups on the basis of glomerular sclerosis proportion tertiles: low (Tertile1 group, proportion of glomerulosclerosis, 0-0%), middle (Tertile2 group, proportion of glomerulosclerosis, 0-5.5%) and high (Tertile3 group, proportion of glomerulosclerosis, 5.8-72.7%) tertiles. The follow-up endpoints were decreased estimated glomerular filtration rate (eGFR) by 20%, end-stage renal disease, and all-cause mortality.
RESULTS: (1) Both, the Tertile1 and Tertile2, groups had significantly lower albumin level and higher 24-h urine protein level than that in the Tertile3 group. Regarding treatment, as the proportion of glomerulosclerosis increases, a more aggressive treatment with glucocorticoids and immunosuppressants should be provided. (2) Correlation analysis showed that the proportion of glomerulosclerosis was positively associated with age (P < 0.05). However, it was negatively associated with eGFR (P < 0.05). (3) Renal tubular atrophy and renal interstitial inflammatory cell infiltration were considered independent correlative factors for glomerulosclerosis. Kaplan-Meier analysis revealed that renal survival rate was significantly lower in patients with a proportion of glomerulosclerosis ≥ 6.45% than in patients with a proportion of glomerulosclerosis < 6.45%. Cox regression analysis revealed that as the proportion of glomerulosclerosis increases, the risk of renal outcomes increases gradually.
CONCLUSIONS: Patients in the Tertile3 (higher proportion of glomerulosclerosis) group had more severe renal pathological damage compared to patients in the Tertile1 and Tertile2 groups. Glomerulosclerosis is a risk factor for renal function progression and poor renal prognosis in patients with IMN. As the proportion of glomerulosclerosis increases, the risk of renal endpoint events increases gradually.

Entities:  

Keywords:  Glomerulosclerosis proportion; Idiopathic membranous nephropathy; Prognosis

Mesh:

Year:  2020        PMID: 32960397     DOI: 10.1007/s11255-020-02641-5

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  19 in total

1.  Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

Authors:  Andrew S Levey; Kai-Uwe Eckardt; Yusuke Tsukamoto; Adeera Levin; Josef Coresh; Jerome Rossert; Dick De Zeeuw; Thomas H Hostetter; Norbert Lameire; Garabed Eknoyan
Journal:  Kidney Int       Date:  2005-06       Impact factor: 10.612

2.  Renal pathology in idiopathic membranous nephropathy: a new perspective.

Authors:  S Troyanov; L Roasio; M Pandes; A M Herzenberg; D C Cattran
Journal:  Kidney Int       Date:  2006-05       Impact factor: 10.612

3.  Low-molecular-weight proteins as prognostic markers in idiopathic membranous nephropathy.

Authors:  Jan A J G van den Brand; Julia M Hofstra; Jack F M Wetzels
Journal:  Clin J Am Soc Nephrol       Date:  2011-12       Impact factor: 8.237

4.  Long-term outcome and prognostic factors of idiopathic membranous nephropathy in the Chinese population.

Authors:  Ke Zuo; Yan Wu; Shi-Jun Li; Feng Xu; Cai-Hong Zeng; Zhi-Hong Liu
Journal:  Clin Nephrol       Date:  2013-06       Impact factor: 0.975

5.  Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China.

Authors:  Xin Xu; Guobao Wang; Nan Chen; Tao Lu; Sheng Nie; Gang Xu; Ping Zhang; Yang Luo; Yongping Wang; Xiaobin Wang; Joel Schwartz; Jian Geng; Fan Fan Hou
Journal:  J Am Soc Nephrol       Date:  2016-06-30       Impact factor: 10.121

6.  Expression of Cell Membrane Antigens in Cells Excreted in the Urinary Sediment Predicts Progression of Renal Disease in Patients with Focal Segmental Glomerulosclerosis.

Authors:  Andrzej Konieczny; Agnieszka Czyżewska-Buczyńska; Monika Ryba; Dagna Rukasz; Magdalena Krajewska; Wojciech Witkiewicz; Zbigniew Hruby
Journal:  Am J Nephrol       Date:  2015       Impact factor: 3.754

7.  Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy.

Authors:  Saskia F Heeringa; Amanda J W Branten; Jeroen K J Deegens; Eric Steenbergen; Jack F M Wetzels
Journal:  Nephrol Dial Transplant       Date:  2007-04-18       Impact factor: 5.992

8.  Analysis of the prognostic risk factors of idiopathic membranous nephropathy using a new surrogate end-point.

Authors:  B O Zhang; Ming Cheng; Ming Yang; Shuai Han; Ying-Hui Zhang; Hong-Guang Shi; Liang Zhu; Xue-Zhi Zhao
Journal:  Biomed Rep       Date:  2015-12-11

9.  Factors affecting the long-term outcomes of idiopathic membranous nephropathy.

Authors:  Hyuk Huh; Hajeong Lee; Jung Pyo Lee; Dong Ki Kim; Sohee Oh; Yun Kyu Oh; Yon Su Kim; Chun Soo Lim
Journal:  BMC Nephrol       Date:  2017-03-27       Impact factor: 2.388

10.  Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial.

Authors:  Andrew Howman; Tracey L Chapman; Maria M Langdon; Caroline Ferguson; Dwomoa Adu; John Feehally; Gillian J Gaskin; David R W Jayne; Donal O'Donoghue; Michael Boulton-Jones; Peter W Mathieson
Journal:  Lancet       Date:  2013-01-09       Impact factor: 79.321

View more
  1 in total

1.  Correlation of Body Mass Index with Clinicopathologic Parameters in Patients with Idiopathic Membranous Nephropathy.

Authors:  Xing Chen; Shuchun Chen; Zelin Li; Xiaoyu Pan; Yujiao Jia; Zhijuan Hu; Kai Niu; Bing Liu; Qingjuan Ren
Journal:  Diabetes Metab Syndr Obes       Date:  2022-06-20       Impact factor: 3.249

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.